Formulation Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
| |
Unit Size 100 µg | |
Storage Instructions Aliquot and store at -20°C. Minimize freezing and thawing. | |
Synonym / Alias Names Htr1a| serotonin receptor 1A| G-protein coupled receptor 18| Gpcr18| 5-hydroxytryptamine receptor 1A| 5-hydroxytryptamine (serotonin) receptor 1A| 5-HT1A receptor| 5-HT-1A| serotonin receptor 1A| G-protein coupled receptor 18| 5-hydroxytryptamine receptor 1A| 5-HT1A receptor| 5-HT-1A| Gpcr18| 5-hydroxytryptamine (serotonin) receptor 1A|Htr1a | |
Accession ID NP_032334.2 | |
Blocking Peptide EBP11006 | |
Immunogen Peptide with sequence C-ERKNERTAEAKRK, from the internal region of the protein sequence according to NP_032334.2. | |
Peptide Sequence C-ERKNERTAEAKRK | |
Purification Method Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. | |
Shipping Instructions Refrigerated | |
Predicted Species Human, Mouse, Rat | |
Reactive Species Human, Mouse | |
Human Gene ID 3350 | |
Mouse Gene ID 15550 | |
Rat Gene ID 24473 | |
Product Grade  | |
ELISA Detection Limit Antibody detection limit dilution 1:128000. | |
Western Blot Approx 45kDa band observed in Mouse Brain lysates (calculated MW of 46.2kDa according to Mouse NP_032334.2). Recommended concentration: 1-3µg/ml. Additional bands of 75 and 18kDa of unknown identity were consistently observed. These bands were successfully blocked by incubation with the immunizing peptide. Primary incubation was 1 hour. Preliminary testing was unsuccessful on Rat Brain for this particular batch. | |
Application Type Pep-ELISA, WB |
Goat Anti-Htr1a (mouse) Antibody
$423.00
| SKU | Unit Size | Price |
|---|---|---|
Select a unit size:
Selected References [{"pmid": 19075042, "intro": "This antibody has been successfully used in Western blot on Human:", "title": "Characterization of serotonin receptors in pregnant human myometrium.", "author": "Cordeaux Y, Pasupathy D, Bacon J, Charnock-Jones DS, Smith GC.", "journal": "J Pharmacol Exp Ther. 2009 Mar;328(3):682-91."}] |